EpiCor® Enhances Immune System in New Clinical Trial
Breaking News By VRP Staff
The yeast fermentation product known as EpiCor was found to enhance the immune
system and significantly reduce cold and flu symptoms, researchers report in the
journal Urologic Nursing.
EpiCor is an immune modulator and powerful antioxidant that causes a four-fold
increase in the activity of natural killer cells, which play an important part
in immune health.
In the new randomized, double-blind, placebo-controlled clinical trial,
researchers studied 116 people recently vaccinated against the flu. Subjects
received either daily supplements of EpiCor (500 mg) or a placebo. The
University of Michigan scientists collected data on the subjects at the study’s
start and after six and 12 weeks.
The researchers found that the subjects given EpiCor experienced significantly
fewer cold and flu symptoms and significantly shorter duration of symptoms,
compared to subjects taking the placebo. Among the 116 study participants, those
who did have symptoms experienced a reduction in the duration of symptoms by 14
percent after taking EpiCor. The overall occurrence of cold and flu symptoms was
reduced by 21 percent in the EpiCor group.
The researchers hope that the results of the current study will encourage future
trials investigating whether EpiCor can reduce cold and flu symptoms in healthy
individuals who have not received any prior flu vaccination.
trusted source of supplements.
did we qualify VRP?
Moyad MA, Robinson LE, Zawada ET, Jr, Kittelsrud JM, Chen DG, Reeves SG, Weaver
SE. Effects of a Modified Yeast Supplement on Cold/Flu Symptoms. Urologic
Nursing. February 2008;28(1): 50-55.
Brainwave Entrainment Audio Technology
| Advanced Human Biochemical